The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takada, Y.
Right arrow Articles by Aggarwal, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takada, Y.
Right arrow Articles by Aggarwal, B. B.
The Journal of Immunology, 2006, 176: 3127-3140.
Copyright © 2006 by The American Association of Immunologists

Acetyl-11-Keto-beta-Boswellic Acid Potentiates Apoptosis, Inhibits Invasion, and Abolishes Osteoclastogenesis by Suppressing NF-{kappa}B and NF-{kappa}B-Regulated Gene Expression1

Yasunari Takada*, Haruyo Ichikawa*, Vladimir Badmaev{dagger} and Bharat B. Aggarwal2,*

* Cytokine Research Section, Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030; and {dagger} Sabinsa Corporation, Piscataway, NJ 08854

Acetyl-11-keto-beta-boswellic acid (AKBA), a component of an Ayurvedic therapeutic plant Boswellia serrata, is a pentacyclic terpenoid active against a large number of inflammatory diseases, including cancer, arthritis, chronic colitis, ulcerative colitis, Crohn’s disease, and bronchial asthma, but the mechanism is poorly understood. We found that AKBA potentiated the apoptosis induced by TNF and chemotherapeutic agents, suppressed TNF-induced invasion, and inhibited receptor activator of NF-{kappa}B ligand-induced osteoclastogenesis, all of which are known to require NF-{kappa}B activation. These observations corresponded with the down-regulation of the expression of NF-{kappa}B-regulated antiapoptotic, proliferative, and angiogenic gene products. As examined by DNA binding, AKBA suppressed both inducible and constitutive NF-{kappa}B activation in tumor cells. It also abrogated NF-{kappa}B activation induced by TNF, IL-1beta, okadaic acid, doxorubicin, LPS, H2O2, PMA, and cigarette smoke. AKBA did not directly affect the binding of NF-{kappa}B to the DNA but inhibited sequentially the TNF-induced activation of I{kappa}B{alpha} kinase (IKK), I{kappa}B{alpha} phosphorylation, I{kappa}B{alpha} ubiquitination, I{kappa}B{alpha} degradation, p65 phosphorylation, and p65 nuclear translocation. AKBA also did not directly modulate IKK activity but suppressed the activation of IKK through inhibition of Akt. Furthermore, AKBA inhibited the NF-{kappa}B-dependent reporter gene expression activated by TNFR type 1, TNFR-associated death domain protein, TNFR-associated factor 2, NF-{kappa}B-inducing kinase, and IKK, but not that activated by the p65 subunit of NF-{kappa}B. Overall, our results indicated that AKBA enhances apoptosis induced by cytokines and chemotherapeutic agents, inhibits invasion, and suppresses osteoclastogenesis through inhibition of NF-{kappa}B-regulated gene expression.




This article has been cited by other articles:


Home page
Anticancer ResHome page
J.-J. LIU and R.-D. DUAN
LY294002 Enhances Boswellic Acid-induced Apoptosis in Colon Cancer Cells
Anticancer Res, August 1, 2009; 29(8): 2987 - 2991.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Pang, Z. Yi, X. Zhang, B. Sung, W. Qu, X. Lian, B. B. Aggarwal, and M. Liu
Acetyl-11-Keto-{beta}-Boswellic Acid Inhibits Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2-Mediated Angiogenesis
Cancer Res., July 15, 2009; 69(14): 5893 - 5900.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
A. B. Kunnumakkara, A. S. Nair, B. Sung, M. K. Pandey, and B. B. Aggarwal
Boswellic Acid Blocks Signal Transducers and Activators of Transcription 3 Signaling, Proliferation, and Survival of Multiple Myeloma via the Protein Tyrosine Phosphatase SHP-1
Mol. Cancer Res., January 1, 2009; 7(1): 118 - 128.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Lu, L. Xia, H. Hua, and Y. Jing
Acetyl-Keto-{beta}-Boswellic Acid Induces Apoptosis through a Death Receptor 5-Mediated Pathway in Prostate Cancer Cells
Cancer Res., February 15, 2008; 68(4): 1180 - 1186.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
J. O. Clarke and G. E. Mullin
A Review of Complementary and Alternative Approaches to Immunomodulation
Nutr Clin Pract, February 1, 2008; 23(1): 49 - 62.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
B. Sung, M. K. Pandey, Y. Nakajima, H. Nishida, T. Konishi, M. M. Chaturvedi, and B. B. Aggarwal
Identification of a novel blocker of I{kappa}B{alpha} kinase activation that enhances apoptosis and inhibits proliferation and invasion by suppressing nuclear factor-{kappa}B
Mol. Cancer Ther., January 1, 2008; 7(1): 191 - 201.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Rengifo-Cam, S. Umar, S. Sarkar, and P. Singh
Antiapoptotic Effects of Progastrin on Pancreatic Cancer Cells Are Mediated by Sustained Activation of Nuclear Factor-{kappa}B
Cancer Res., August 1, 2007; 67(15): 7266 - 7274.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.